Clonal hematopoiesis in frequent blood donors, immune microenvironment and bispecific antibody response in diffuse large B-cell lymphoma, and blinatumomab as part of early consolidation therapy in CD19-positive Ph-negative B-cell acute lymphoblastic lymphoma
Blood Podcast
00:00
Exploring Immune Microenvironments and Blinatumomab Efficacy in Leukemia Treatments
This chapter explores the role of immune microenvironments in diffuse large B-cell lymphoma and presents significant findings from a study on blinatumomab for acute lymphoblastic leukemia. It highlights the drug's efficacy, safety, and the positive impact of minimal residual disease status on patient survival rates.
Play episode from 12:42
Transcript
